Abstract
In the present study, two molecular forms of goat lung cystatin (GLC), I and II, were purified to homogeneity by a two-step procedure including ammonium sulfate precipitation (40–60%) and ion exchange chromatography. The inhibitor forms migrated as single bands under native and SDS-PAGE with and without reducing agent giving molecular mass of 66.4 and 76.4 kDa, respectively. GLC-I possesses 0.07% and GLC-II 2.3% carbohydrate content and no -SH groups. GLC-I showed greater affinity for papain than for ficin and bromelain. Immunological studies showed that the inhibitor was pure and there was cross reactivity between anti-GLC-I serum and goat brain cystatin. Both inhibitor forms were stable in the pH range of 3–10 and up to 75°C. GLC-I was found to possess 49% α-helical structure by CD spectroscopy. The inhibitor-papain complexes showed conformational changes as invoked by UV and fluorescence spectroscopic studies.
Similar content being viewed by others
Abbreviations
- GLC:
-
goat lung cystatin
References
Barrett, A. J., Rawlings, N. D., Davies, M. E., Machleidt, W., Salvesen, G., and Turk, V. (1986) in Proteinase Inhibitors: Cysteine Proteinase Inhibitors of the Cystatin Superfamily (Barrett, A. J., and Salvesen, G., eds.) Elsevier, Amsterdam, pp. 515–569.
Dayhoff, M. O. (1976) in Atlas of Protein Sequence and Structure (Dayhoff, M. O., ed.) Vol. 5, National Biomedical Research Foundation, Washington, D.C., pp. 1–8.
Jankowska, E., Wiezk, W., and Grzonka, Z. (2004) Eur. Biophys. J., 33, 454–460.
Schnittger, S, Gopal Rao, V. V. N, Abrahamson, M., and Hansmann, I. (1993) Genomics, 16, 50–55.
Kato, H., Nagasawa, S., and Iwanaga, S. (1981) Meth. Enzymol., 251, 382–397.
Trabant, A., Gay, O. N., and Gay, R. S. (1991) Arthritis Rheum., 34, 444.
Delaisse, J. M., Ledent, P., and Vaes, G. (1991) Biochem. J., 279, 167–174.
Kabanda, A., Goffin, E., and Bernard, A. (1995) Kidney Int., 48, 1946–1952.
Bernstein, H. G., Kirschke, H., and Wiederander, B. (1996) Mol. Chem. Neuropathol., 27, 225–247.
Buttle, D. J., Burnett, D., and Abrahamson, M. (1990) Scand. J. Clin. Lab. Invest., 50, 509–516.
Jensson, O., Palsdottir, A., Thorsteinsson, L., Arnason, A., Abrahamson, M., Olafsson, I., and Grubb, A. (1990) Biol. Chem. Hoppe-Seyler, 71, 229–232.
Kopper, P., Baici, A., Keist, R., Matzku, S., and Keller, R. (1994) Exp. Cell. Biol., 52, 293–299.
Shi, G. P., Sukhova, G. K., Grubb, A., Ducharme, A., Rhode, L. H., Lee, R. T., Ridker, P. M., Libby, P., and Chapman, H. A. (1999) J. Clin. Invest., 104, 1191–1197.
Assfalq Machleidt, I., Jochum, M., Klaubert, W., and Machleidt, W. (1998) Biol. Chem. Hoppe-Seyler, 369, 263–269.
North, M. J., Moltram, J. C., and Coombs, G. H. (1990) Parasitol. Today, 6, 270–275.
Bige, L., Ouali, A., and Valin, C. (1985) Biochim. Biophys. Acta, 843, 269–273.
Zehra, S., Shahid, P. B., and Bano, B. (2005) Comp. Biochem. Physiol., Pt. B, 142, 361–368.
Jarvinen, M., and Rinnie, A. (1982) Biochim. Biophys. Acta, 708, 210–217.
Green, G. D. J., Kembhavi, A. A., Davies, M. E., and Barrett, A. J. (1984) Biochem. J., 218, 39–46.
Rashid, F., Sharma, S., and Bano, B. (2006) Placenta, 2, 822–831.
Shahid, P. B., Zehra, S., and Bano, B. (2005) Protein J., 24, 95–102.
Synnes, M. (1998) Comp. Biochem. Physiol., Pt. B, 121, 257–264.
Aghajanyan, H. G., Arzumanyan, A. M., Arutunyan, A. A., and Akyopyan, T. N. (1988) Neurochem. Res., 13, 721–727.
Sumbhul, S., and Bano, B. (2006) Neurochem. Res., 31, 1327–1333.
Wolters, P. J., and Chapman, H. A. (2000) Respir. Res., 1, 170–177.
Kunitz, M. (1947) J. Gen. Physiol., 30, 291–310.
Lowry, O. H., Rosebrough, N. J., and Farr, A. L. (1951) J. Biol. Chem., 193, 265–270.
Laemmli, U. K. (1970) Nature, 227, 680–685.
Ellman, R. (1969) Biochem. Meth., 19, 446–451.
Dubois, M., Gilles, M. A., Hamilton, J. K., Rebers, P. A., and Smith, F. (1956) Anal. Chem., 28, 350–354.
Ouchterlony, O. (1962) Acta Pathol. Microbiol. Scand., 26, 579–599.
Voller, A., Bidwell, D. E., and Bartlett, A. (1976) Bull. World Health Organ., 53, 55–65.
Hiriado, M., Iwata, A., Niinobe, E. M., and Fuji, S. (1981) Biochim. Biophys. Acta, 669, 21–27.
Zabari, M, Berri, M, Rouchon, M, et al. (1993) Biochimie, 75, 937–945.
Zabari, M, Berri, M, Rouchon, P, Zamora, F, Tassy, C, Ribadeau-Dumas, B., and Ouali, A. (1993) Biochimie, 75, 937–945.
Wu, J., and Haard, N. F. (2000) Biochem. Physiol., Pt. C, 127, 209–220.
Ni, J., Fernandez, M. A., Danielsson, L., Chillakuru, R. A., Zhang, J., Grubb, A., Su, J., Gentz, R., and Abrahamson, M. (1998) J. Biol. Chem., 273, 24797–24804.
Sotiropoulou, G., Anisowicz, A., and Sager, R. (1997) J. Biol. Chem., 272, 903–910.
Warwas, M., and Sawicki, G. (1985) Placenta, 6, 455–463.
Li, F., An, M., and Baynes, T. L. (2000) Comp. Biochem. Physiol., Pt. B, 125, 493–502.
Nicklin, M. J. H., and Barret, A. J. (1984) Biochem. J., 223, 245–253.
Donovan, J. W. (1969) in Physical Principles and Techniques of Protein Chemistry, Pt. A (Leach, S. J., ed.) Academic Press, New York, pp. 101–170.
Donovan, J. W. (1973) Meth. Enzymol., 27, 525–548.
Friefelder, D. (1982) Physical Biochemistry, 2nd Edn., WH Freeman and Company, New York.
James, F. L., Jeffery, R. T., Wesley, J. S., and Alan, G. L. (1979) Eur. J. Biochem., 101, 153–161.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2009, Vol. 74, No. 7, pp. 963–971.
Rights and permissions
About this article
Cite this article
Khan, M.S., Bano, B. Purification, characterization and kinetics of thiol protease inhibitor from goat (Capra hircus) lung. Biochemistry Moscow 74, 781–788 (2009). https://doi.org/10.1134/S0006297909070116
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297909070116